These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 24100389)

  • 1. The role of acetylation in TLR4-mediated innate immune responses.
    Hu X; Yu Y; Eugene Chin Y; Xia Q
    Immunol Cell Biol; 2013; 91(10):611-4. PubMed ID: 24100389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular cloning and characterization of LrTLR4, analysis of its inductive expression and associated down-stream signaling molecules following lipopolysaccharide stimulation and Gram-negative bacterial infection.
    Samanta M; Basu M; Swain B; Paichha M; Lenka SS; Das S; Jayasankar P; Maiti NK
    Fish Shellfish Immunol; 2017 Jan; 60():164-176. PubMed ID: 27838566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD13 restricts TLR4 endocytic signal transduction in inflammation.
    Ghosh M; Subramani J; Rahman MM; Shapiro LH
    J Immunol; 2015 May; 194(9):4466-76. PubMed ID: 25801433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of innate immune responses by Toll-like receptors.
    Takeda K; Akira S
    Jpn J Infect Dis; 2001 Dec; 54(6):209-19. PubMed ID: 11862002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydroxysafflor yellow A exerts neuroprotective effects in cerebral ischemia reperfusion-injured mice by suppressing the innate immune TLR4-inducing pathway.
    Lv Y; Qian Y; Fu L; Chen X; Zhong H; Wei X
    Eur J Pharmacol; 2015 Dec; 769():324-32. PubMed ID: 26607471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LPS/TLR4 signal transduction pathway.
    Lu YC; Yeh WC; Ohashi PS
    Cytokine; 2008 May; 42(2):145-151. PubMed ID: 18304834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible regulation of Toll-like receptor 4 by lysine acetylation through LPCAT2 activity in RAW264.7 cells.
    Poloamina VI; Abate W; Fejer G; Jackson SK
    Biosci Rep; 2022 Jul; 42(7):. PubMed ID: 35735109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early innate immune responses to bacterial LPS.
    Rosadini CV; Kagan JC
    Curr Opin Immunol; 2017 Feb; 44():14-19. PubMed ID: 27842237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The induction of innate and adaptive immunity by biodegradable poly(γ-glutamic acid) nanoparticles via a TLR4 and MyD88 signaling pathway.
    Uto T; Akagi T; Yoshinaga K; Toyama M; Akashi M; Baba M
    Biomaterials; 2011 Aug; 32(22):5206-12. PubMed ID: 21492934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signaling through Toll-like receptor 4 and mast cell-dependent innate immunity responses.
    Avila M; Gonzalez-Espinosa C
    IUBMB Life; 2011 Oct; 63(10):873-80. PubMed ID: 21905201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipopolysaccharides-Induced Suppression of Innate-Like B Cell Apoptosis Is Enhanced by CpG Oligodeoxynucleotide and Requires Toll-Like Receptors 2 and 4.
    Yu X; Wang Y; Lin J; Hu Y; Kawai T; Taubman MA; Han X
    PLoS One; 2016; 11(11):e0165862. PubMed ID: 27812176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chaperones and transport proteins regulate TLR4 trafficking and activation.
    Saitoh S
    Immunobiology; 2009; 214(7):594-600. PubMed ID: 19250701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AMPK activation by metformin inhibits local innate immune responses in the isolated rat heart by suppression of TLR 4-related pathway.
    Vaez H; Najafi M; Rameshrad M; Toutounchi NS; Garjani M; Barar J; Garjani A
    Int Immunopharmacol; 2016 Nov; 40():501-507. PubMed ID: 27756052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toll-like receptor 4 deficiency increases resistance in sepsis-induced immune dysfunction.
    Cao C; Chai Y; Shou S; Wang J; Huang Y; Ma T
    Int Immunopharmacol; 2018 Jan; 54():169-176. PubMed ID: 29149705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of Presenilin 2 Function Is Associated with Defective LPS-Mediated Innate Immune Responsiveness.
    Agrawal V; Sawhney N; Hickey E; McCarthy JV
    Mol Neurobiol; 2016 Jul; 53(5):3428-3438. PubMed ID: 26081153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptome sequencing of microglial cells stimulated with TLR3 and TLR4 ligands.
    Das A; Chai JC; Kim SH; Lee YS; Park KS; Jung KH; Chai YG
    BMC Genomics; 2015 Jul; 16(1):517. PubMed ID: 26159724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic targeting of innate immunity with Toll-like receptor 4 (TLR4) antagonists.
    Peri F; Piazza M
    Biotechnol Adv; 2012; 30(1):251-60. PubMed ID: 21664961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential responses of mast cell Toll-like receptors 2 and 4 in allergy and innate immunity.
    Supajatura V; Ushio H; Nakao A; Akira S; Okumura K; Ra C; Ogawa H
    J Clin Invest; 2002 May; 109(10):1351-9. PubMed ID: 12021251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Separation of zinc-dependent and zinc-independent events during early LPS-stimulated TLR4 signaling in macrophage cells.
    Wan Y; Petris MJ; Peck SC
    FEBS Lett; 2014 Aug; 588(17):2928-35. PubMed ID: 24911202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TLR4: An Important Molecule Participating in Either Anti-Human Papillomavirus Immune Responses or Development of Its Related Cancers.
    Bahramabadi R; Dabiri S; Iranpour M; Kazemi Arababadi M
    Viral Immunol; 2019 Dec; 32(10):417-423. PubMed ID: 31721657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.